Robert Anders
Overview
Explore the profile of Robert Anders including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
3780
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DAlessio A, Stefanini B, Blanter J, Adegbite B, Crowley F, Yip V, et al.
Lancet Oncol
. 2024 Oct;
25(11):1465-1475.
PMID: 39437804
Background: Neoadjuvant use of immune checkpoint inhibitors (ICIs) before liver resection results in pathological tumour regression in patients with hepatocellular carcinoma. We aimed to describe the characteristics of pathological responses...
2.
Ahmadi A, Song G, Gao T, Ma J, Han X, Hu M, et al.
Elife
. 2023 Dec;
12.
PMID: 38055614
The pathogenesis of antibodies in severe alcoholic hepatitis (SAH) remains unknown. We analyzed immunoglobulins (Ig) in explanted livers from SAH patients (n=45) undergoing liver transplantation and tissues from corresponding healthy...
3.
Shu D, Ho W, Kagohara L, Girgis A, Shin S, Danilova L, et al.
bioRxiv
. 2023 Oct;
PMID: 37904980
Neoadjuvant immunotherapy is thought to produce long-term remissions through induction of antitumor immune responses before removal of the primary tumor. Tertiary lymphoid structures (TLS), germinal center-like structures that can arise...
4.
Gupta A, Zorzi J, Ho W, Baretti M, Azad N, Griffith P, et al.
Healthcare (Basel)
. 2023 Sep;
11(18).
PMID: 37761768
Health-related quality of life (HRQoL) is known to be an important prognostic indicator and clinical endpoint for patients with hepatocellular carcinoma (HCC). However, the correlation of the Barcelona Clinic Liver...
5.
Benson A, DAngelica M, Abrams T, Abbott D, Ahmed A, Anaya D, et al.
J Natl Compr Canc Netw
. 2023 Jul;
21(7):694-704.
PMID: 37433432
In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary Tract Cancers provide recommendations for...
6.
Heumann T, Judkins C, Li K, Lim S, Hoare J, Parkinson R, et al.
Nat Commun
. 2023 Jun;
14(1):3650.
PMID: 37339979
A neoadjuvant immunotherapy platform clinical trial allows for rapid evaluation of treatment-related changes in tumors and identifying targets to optimize treatment responses. We enrolled patients with resectable pancreatic adenocarcinoma into...
7.
Ogholikhan S, Schwarz K, Anders R
JPGN Rep
. 2023 May;
2(2):e053.
PMID: 37207070
Objective: To test our hypothesis that BA liver tissues would show clonal expansion of 1 or several TCRs. Methods: The complementarity-determining region 3 region of the β-chain of the TCR...
8.
Brahmer J, Drake C, Wollner I, Powderly J, Picus J, Sharfman W, et al.
J Clin Oncol
. 2023 Jan;
41(4):715-723.
PMID: 36706735
Purpose: Programmed death-1 (PD-1), an inhibitory receptor expressed on activated T cells, may suppress antitumor immunity. This phase I study sought to determine the safety and tolerability of anti-PD-1 blockade...
9.
Koury M, Agarwal R, Chertow G, Eckardt K, Fishbane S, Ganz T, et al.
Am J Hematol
. 2022 Jun;
97(9):1178-1188.
PMID: 35751858
Patients with chronic kidney disease (CKD) develop anemia largely because of inappropriately low erythropoietin (EPO) production and insufficient iron available to erythroid precursors. In four phase 3, randomized, open-label, clinical...
10.
Xie F, Ding D, Lin C, Cunningham D, Wright M, Javed A, et al.
JCO Precis Oncol
. 2022 Jun;
6:e2100404.
PMID: 35737913
Purpose: Genetic alterations in many components of the homologous recombination, DNA damage response, and repair (HR-DDR) pathway are involved in the hereditary cancer syndromes, including familial pancreatic cancer. HR-DDR genes...